No end in sight for telomerase-targeted cancer drugs.
- Published in:
- Nature Medicine, 2013, v. 19, n. 1, p. 6, doi. 10.1038/nm0113-6
- By:
- Publication type:
- Article
Works matching DE "GERON Corp."
Results: 31
1
2
US stem cell climate improves, raising concerns elsewhere.
- Published in:
- Nature Medicine, 2009, v. 15, n. 3, p. 224, doi. 10.1038/nm0309-224a
- By:
- Publication type:
- Article
3
News in brief.
- Published in:
- Nature Medicine, 2009, v. 15, n. 3, p. 228, doi. 10.1038/nm0309-228
- Publication type:
- Article
4
Xenotransplant News.
- Published in:
- Xenotransplantation, 2004, v. 11, n. 5, p. 387, doi. 10.1111/j.1399-3089.2004.00161.x
- By:
- Publication type:
- Article
5
Patentability of Inventions Related to Human Embryonic Stem Cells.
- Published in:
- Juridica International, 2011, v. 18, p. 94
- By:
- Publication type:
- Article
6
Alliances.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 70
- Publication type:
- Article
7
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 11, p. 828, doi. 10.1038/nrd3317
- Publication type:
- Article
8
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 182, doi. 10.1038/nrd2848
- Publication type:
- Article
9
Stem Cell Therapy: Within Reach.
- Published in:
- Eye Care Review, 2009, v. 3, n. 1, p. 55
- By:
- Publication type:
- Article
10
Geron trial resumes, but standards for stem cell trials remain elusive.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 10, p. 989, doi. 10.1038/nbt1010-989
- By:
- Publication type:
- Article
11
Fits and starts for Geron.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 10, p. 877, doi. 10.1038/nbt1009-877b
- By:
- Publication type:
- Article
12
Geron gets green light for human trial of ES cell–derived product.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 3, p. 213, doi. 10.1038/nbt0309-213a
- By:
- Publication type:
- Article
13
Caveat e-mptor.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 4, p. 357, doi. 10.1038/74321
- Publication type:
- Article
14
Geron?Roslin alliance aims broadly at degenerative diseases.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 6, p. 529, doi. 10.1038/9828
- By:
- Publication type:
- Article
15
Time to lift embryo research ban.
- Published in:
- Nature, 1998, v. 396, n. 6707, p. 97, doi. 10.1038/23983
- Publication type:
- Article
16
Research Highlights.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 3, p. 401, doi. 10.1038/mt.2009.20
- Publication type:
- Article
17
FDA approves stem cell clinical trial.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2010, v. 182, n. 12, p. E584
- By:
- Publication type:
- Article
18
Partners turn to court over stem-cell rights.
- Published in:
- Nature, 2001, v. 412, n. 6849, p. 753, doi. 10.1038/35090694
- By:
- Publication type:
- Article
19
Eternal verities, eternal questions.
- Published in:
- Nature, 2000, v. 404, n. 6777, p. 439, doi. 10.1038/35006520
- By:
- Publication type:
- Article
20
US stem-cell pioneers buy 'Dolly' cloning company.
- Published in:
- Nature, 1999, v. 399, n. 6732, p. 92, doi. 10.1038/20026
- By:
- Publication type:
- Article
21
Stem cell hype: Media portrayal of therapy translation.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 278, p. 1, doi. 10.1126/scitranslmed.3010496
- By:
- Publication type:
- Article
22
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.
- Published in:
- Kennedy Institute of Ethics Journal, 2012, v. 22, n. 3, p. 243, doi. 10.1353/ken.2012.0013
- By:
- Publication type:
- Article
23
Stem cells ready for prime time.
- Published in:
- Nature, 2009, v. 457, n. 7229, p. 516, doi. 10.1038/457516a
- By:
- Publication type:
- Article
24
Geron & the Demise of Embryonic Stem-Cell Science.
- Published in:
- Human Life Review, 2012, v. 38, n. 1, p. 61
- By:
- Publication type:
- Article
25
Funding windfall rescues abandoned stem-cell trial.
- Published in:
- Nature, 2014, v. 510, n. 7503, p. 18, doi. 10.1038/510018a
- By:
- Publication type:
- Article
26
Stem-cell pioneer bows out.
- Published in:
- Nature, 2011, v. 479, n. 7374, p. 459, doi. 10.1038/479459a
- By:
- Publication type:
- Article
27
First Rounders: Michael West.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 4, p. 313, doi. 10.1038/nbt0414-313
- Publication type:
- Article
28
BioTime acquires Geron's stem cell program.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 94, doi. 10.1038/nbt0213-94a
- By:
- Publication type:
- Article
29
Geron's quixotic fate.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 6, p. 497, doi. 10.1038/nbt.2253
- By:
- Publication type:
- Article
30
Embryonic stem cell pioneer Geron exits field, cuts losses.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 1, p. 12, doi. 10.1038/nbt0112-12
- By:
- Publication type:
- Article
31
Geron gets new US stem cell patent.
- Published in:
- Journal of Intellectual Property Rights, 2005, v. 10, n. 1, p. 84
- Publication type:
- Article